Recurrent pneumococcal bacteremia. A warning of immunodeficiency.

BACKGROUND Recurrent pneumococcal infections are known to occur occasionally in patients with profound immune defects. We performed a case-control analysis of recurrent pneumococcal bacteremias). PATIENTS AND METHODS The 547 episodes of Streptococcus pneumoniae bacteremia detected from January 1, 1985, to December 31, 1994, were reviewed. We selected all cases with more than 1 episode separated by 30 days or more ("cases") and compared each of them with 2 controls (patients with single episodes of pneumococcal bacteremia). RESULTS Fifteen patients (2.8%) had 31 episodes of pneumococcal bacteremia. Except for multiple myeloma (P < .02), the underlying disease was remarkably similar among patients with single and recurrent episodes of pneumococcal bacteremia. However, among patients positive for human immunodeficiency virus infection, those who had recurrences were at a more advanced stage of their disease than those who did not. The presence of an ultimately fatal underlying condition was more frequent in case patients (P < .001). Overall, 47% of the patients with recurrences died during their second episode of pneumococcal bacteremia. CONCLUSIONS Our data suggest that recurrence is more than anecdotal in patients with bacteremic infections caused by S pneumoniae (2.8%). We believe that recurrence is a warning sign of immunodeficiency. Patients with multiple myeloma, human immunodeficiency virus infection, solid organ tumors, and chronic liver disease with bacteremic pneumococcal infections should be offered antipneumococcal vaccine and other potentially preventive measures, despite doubts about their efficacy. This is justified by the high mortality rate associated with recurrent episodes (47%).

[1]  D. Parks,et al.  The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention. , 1994, The Journal of infectious diseases.

[2]  Claude Carbón,et al.  Bactériémies à streptococcus pneumoniae et infection par le VIH : étude rétrospective de 41 épisodes chez 30 malades , 1994 .

[3]  J. Miro,et al.  Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  A. Gurtman,et al.  Pseudomonas aeruginosa bacteremia in patients with AIDS. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Weiser,et al.  Recurrent pneumococcal bacteremia in normal children. , 1994, The Pediatric infectious disease journal.

[6]  R. Arbeit,et al.  Recurrent Escherichia coli bacteremia , 1994, Journal of clinical microbiology.

[7]  A. Planes,et al.  Incidence and risk factors of recurrent episodes of bacteremia in adults. , 1994, Archives of internal medicine.

[8]  I. Julander,et al.  Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations--Huntington, WVa, and Stockholm, Sweden. , 1993, Chest.

[9]  W. Gransden,et al.  Recurrent pneumococcal bacteremia. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Sperber,et al.  Reactivation of tuberculosis during therapy with corticosteroids. , 1992, Clinical Infectious Diseases.

[11]  E. Bouza,et al.  Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. , 1992, Archives of internal medicine.

[12]  C. Leach,et al.  Relapsing pneumococcal bacteremia in immunocompromised patients. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Mulligan,et al.  Recurrent Staphylococcus aureus bacteremia , 1992, Journal of clinical microbiology.

[14]  G. Rutherford,et al.  The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. , 1990, The Journal of infectious diseases.

[15]  R. Insel,et al.  Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides. , 1988, The Pediatric infectious disease journal.

[16]  E. Gelfand,et al.  Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia. , 1987, The American journal of medicine.

[17]  B. Rudensky,et al.  Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature. , 1987, Israel journal of medical sciences.

[18]  L. Matter,et al.  Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4. , 1985, The New England journal of medicine.

[19]  I. Phillips,et al.  Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. , 1985, British medical journal.

[20]  F. Ruben,et al.  Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. , 1984, The American journal of medicine.

[21]  E. Hook,et al.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. , 1983, JAMA.

[22]  G. Mccracken,et al.  Recrudescence and relapse in bacterial meningitis of childhood. , 1981, Pediatrics.

[23]  P. Shackelford,et al.  Recurrent pneumococcal sepsis and defective opsonization after pneumococcal capsular polysaccharide vaccine in a child with nephrotic syndrome. , 1980, The Journal of pediatrics.

[24]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .

[25]  E. Bouza,et al.  Penicillin-resistant pneumococci in adult disease with special reference to AIDS patients. , 1995, Microbial drug resistance.

[26]  A. Brauner,et al.  Recurrent Escherichia coli bacteraemia--clinical characteristics and bacterial properties. , 1994, The Journal of infection.

[27]  C. Sponsel,et al.  Recurrent pneumococcal meningitis. , 1994, Postgraduate medicine.

[28]  P. Thompson,et al.  Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. , 1993, The Journal of infectious diseases.

[29]  W. Zimmerli,et al.  Humoral immune response to pneumococcal antigen 23-F in an asplenic patient with recurrent fulminant pneumococcaemia. , 1991, The Journal of infection.

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.